drugset / Trial / NCT00232336
Quetiapine for Cocaine Use and Cravings
Phase 4
Completed
42 enrolled
Seattle Institute for Biomedical and Clinical Research
AstraZeneca · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study was to collect pilot data on whether quetiapine may be effective in the reduction of cocaine use and cravings in cocaine dependent individuals.
Timeline
- Start
- 2003-10
- Primary completion
- 2006-01
- Completion
- 2006-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 600 mg | — |